Plain-English translation of NCT06292897 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers want to understand why prostate cancer may behave differently in obese patients compared to those at normal weight. This study will examine tissue samples from prostate cancer patients to look at specific proteins and immune cells that may be affected by weight and obesity, helping doctors learn whether weight management could influence cancer progression.
Studies suggest that obesity may speed up prostate cancer growth, but scientists don't fully understand the biological mechanisms behind this connection. This research aims to fill that gap by examining how obesity changes the chemical environment inside tumors and weakens the immune system's ability to fight cancer.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will examine tissue samples that may already be available from your prostate cancer diagnosis or biopsy. They will analyze these samples in the laboratory to measure specific proteins and immune cells. There are no drugs to take or ongoing appointments described—this is primarily a research study of existing tissue material.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
National Research Council
Enrollment target
~25 participants
Started
March 2023
Primary completion
September 2026
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in March 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giancarlo Albo, MD,
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.